Archive ready

バイエル薬品株式会社に対する報告命令を行いました

https://www.mhlw.go.jp/stf/houdou/0000165950.html

April 4, 2026 at 03:31 AM JST•The archive page, viewer, and downloads use this saved version.

April 4, 2026 at 03:31 AM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

バイエル薬品株式会社に対する報告命令を行いました

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.mhlw.go.jp/stf/houdou/0000165950.html

StartedApril 4, 2026 at 03:31 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page announces that the Ministry of Health, Labour and Welfare issued a reporting order to Bayer Yakuhin Ltd. on May 29, 2017. The order was issued under the Pharmaceutical Affairs Law following the company's disclosure of delayed reporting of 12 adverse event cases for Xarelto (rivaroxaban). The order requires Bayer to investigate all its pharmaceutical products for unreported or delayed adverse event cases and submit a report on the causes of any delays by July 31, 2017.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.